Featured News
CEO & Founder Cate Dyer Discusses Cell & Gene Therapies with the Video Journal of Regenerative Medicine
Cate’s discussion focused on the importance of creating a closed-loop system for cell and gene clinical therapies by leveraging existing partnerships with hospital systems and the 8 U.S.-based StemExpress clinical collection centers within nearby proximity to industry-leading hospital systems.
Read More2022 Advanced Therapies Week Audiogram
Live from Phacilitate’s 2022 Advanced Therapies Week in Miami, Florida Take a moment to watch the audiogram of Cate Dyer, CEO & Founder of StemExpress, speak on the importance of partnerships in cell therapy at Phacilitate’s 2022 Advanced Therapies Week. Picking the Right Partner from Product and Process Development Through Commercialization Qualifying how you choose…
Read MoreBiocom California Member Spotlight
Biocom California recently sat down with Cate Dyer, CEO & Founder of StemExpress to hear what it took to bring her vision to life and how the company built an end-to-end COVID-19 testing solution in a matter of weeks from the very beginning of the pandemic. The article discusses (1) the roots of StemExpress, (2)…
Read More